Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | KCNN4 | O15554 | 3/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 2/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1384161 | 0.81 | CYP1A2 (0.44) | CYP1A2CYP2C9CYP2C19ALDH1A1TSHR | |
| SCHEMBL1253796 | 0.77 | ALDH1A1 (0.48) | CYP1A2CYP2C9CYP2C19ALDH1A1TSHR | |
| SCHEMBL6014072 | 0.77 | TSHR (0.52) | CYP1A2CYP2C9CYP2C19ALDH1A1TSHR | |
| SCHEMBL5184997 | 0.77 | KCNN4 (0.52) | CYP1A2CYP2C9CYP2C19ALDH1A1TSHR | |
| SCHEMBL4887210 | 0.75 | KDM4E (0.48) | CYP1A2CYP2C9CYP2C19ALDH1A1TSHR | |
| SCHEMBL902761 | 0.75 | ALDH1A1 (0.42) | CYP1A2CYP2C9CYP2C19ALDH1A1TSHR | |
| SCHEMBL10608360 | 0.75 | ALDH1A1 (0.42) | CYP1A2CYP2C9CYP2C19ALDH1A1TSHR | |
| SCHEMBL7173455 | 0.73 | CYP1A2 (0.48) | CYP1A2CYP2C9CYP2C19ALDH1A1TSHR | |
| SCHEMBL3173030 | 0.73 | KCNN4 (0.47) | CYP1A2CYP2C9CYP2C19ALDH1A1TSHR | |
| Triphenylmethanol SCHEMBL456603 | 0.73 | CYP19A1 (0.50) | CYP1A2CYP2C9CYP2C19ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108117779-A | Environment-friendly coating capable of generating negative oxygen ions and preparation method thereof | 金华联创塑粉科技有限公司 | 2018-06-05 | — | — | CN | claimed |
| CN-118325004-A | Phenolic hydroxyl group-containing resin, photosensitive resin composition, curable composition, and resist film | DIC株式会社 | 2024-07-12 | — | — | CN | disclosed |
| CN-118011733-A | Positive photosensitive resin composition, resist film, resist underlayer film, and resist permanent film | DIC株式会社 | 2024-05-10 | — | — | CN | disclosed |
| CN-117487097-A | Surface-modified carbon black, carbon black dispersion, and black resist composition | DIC株式会社 | 2024-02-02 | — | — | CN | disclosed |
| CN-117321109-A | Phenolic hydroxyl group-containing resin | DIC株式会社 | 2023-12-29 | — | — | CN | disclosed |
| WO-2023224055-A1 | PHARMACEUTICAL COMPOSITION FOR USE IN THERAPEUTIC OR PROPHYLACTIC METHOD FOR KIDNEY INJURY, COMBINED MEDICINE CONTAINING SAID PHARMACEUTICAL COMPOSITION, AND CCBL1 INHIBITOR | 学校法人藤田学園 | 2023-11-23 | — | — | WO | disclosed |
| CN-116023607-A | Phenolic hydroxyl group-containing resin | DIC株式会社 | 2023-04-28 | — | — | CN | disclosed |
| CN-115873214-A | Epoxy resin, photosensitive resin composition, resist film, curable composition, and cured film | DIC株式会社 | 2023-03-31 | — | — | CN | disclosed |
| US-11129781-B2 | Agent for hair deforming treatment | KAO CORPORATION (JP) | 2021-09-28 | — | — | US | disclosed |
| CN-107652222-B | Oxime ester photoinitiators | 巴斯夫欧洲公司 | 2021-09-10 | — | — | CN | disclosed |
| EP-2346044-A1 | UV-CURABLE RESIN COMPOSITIONS FOR OPTICAL DISCS AND CURED PRODUCTS THEREOF | Nippon Kayaku Kabushiki Kaisha (JP) | 2011-07-20 | — | — | EP | disclosed |
| EP-1881835-A1 | TRIAZINE COMPOUNDS AND COMPOSITIONS THEREOF FOR THE TREATMENT OF CANCERS | ProMetic BioSciences Inc. (CA) | 2008-01-30 | — | — | EP | disclosed |
| CN-1882680-A | Cleaning composition | RECKITT BENCKISER INC (US) | 2006-12-20 | — | — | CN | disclosed |
| CN-1882679-A | Cleaning composition | RECKITT BENCKISER INC (US) | 2006-12-20 | — | — | CN | disclosed |
| WO-2006122431-A1 | TRIAZINE COMPOUNDS AND COMPOSITIONS THEREOF FOR THE TREATMENT OF CANCERS | PROMETIC BIOSCIENCES INC. (CA) | 2006-11-23 | — | — | WO | disclosed |
| US-6294521-B1 | SUGAR PHOSPHATES | AUSTRALIAN NATIONAL UNIVERSITY (AU) | 2001-09-25 | — | — | US | disclosed |
| EP-0057777-B1 | DIBENZOXAZONINE, DIBENZOXAZECINE, DIBENZOXAAZACYCLOUNDECANE DERIVATIVES AND THEIR CORRESPONDING THIA- AND AZA DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS | AKZO N.V. (NL) | 1984-10-10 | — | — | EP | disclosed |
| US-4374133-A | PSYCHOLOGICAL DISORDERS | AKZO N.V. (NL) | 1983-02-15 | — | — | US | disclosed |
| EP-0057777-A1 | Dibenzoxazonine, dibenzoxazecine, dibenzoxaazacycloundecane derivatives and their corresponding thia- and aza derivatives, their preparation and pharmaceutical compositions | AKZO N.V. (NL) | 1982-08-18 | — | — | EP | disclosed |
| WO-1982002199-A1 | TRICYCLIC COMPOUNDS | AKZO NV (NL) | 1982-07-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11129781-B2 | Agent for hair deforming treatment | GRHPR, SLC26A4, COL1A1 | CYP1A2 2314/4885CYP2C9 3671/4885CYP2C19 3223/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.